Alpha Tau Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	8.89	9.26	11.25	2.34	1.7	1.37
Research & Development	26.57	26.42	20.89	11.45	7.54	6.64
Operating Expenses	35.46	35.68	32.14	13.79	9.24	8.01
Operating Income	-35.46	-35.68	-32.14	-13.79	-9.24	-8.01
Interest Expense	-0.08	-0.08	-	-	-	-
Interest & Investment Income	4.8	4.83	1.79	0.21	0.61	0.78
Currency Exchange Gain (Loss)	-0.21	-0.21	0.41	-0.41	0.1	-0.08
Other Non Operating Income (Expenses)	1.99	1.99	-3.81	-13.27	-0.19	-1.01
Pretax Income	-28.96	-29.14	-33.74	-27.26	-8.72	-8.32
Income Tax Expense	-0	0.02	0.02	0.01	0.16	0.15
Earnings From Continuing Operations	-28.95	-29.16	-33.76	-27.27	-8.88	-8.46
Minority Interest in Earnings	-	-	-	-	-	0.1
Net Income	-28.95	-29.16	-33.76	-27.27	-8.88	-8.37
Net Income to Common	-28.95	-29.16	-33.76	-27.27	-8.88	-8.37
Shares Outstanding (Basic)	70	69	64	41	40	34
Shares Outstanding (Diluted)	70	69	64	41	40	34
Shares Change (YoY)	0.79%	9.20%	56.74%	0.64%	19.10%	-
EPS (Basic)	-0.42	-0.42	-0.53	-0.67	-0.22	-0.25
EPS (Diluted)	-0.42	-0.42	-0.53	-0.67	-0.22	-0.25
Free Cash Flow	-	-24.36	-24.78	-14.74	-11.02	-8.2
Free Cash Flow Per Share	-	-0.35	-0.39	-0.36	-0.27	-0.24
EBITDA	-34.36	-34.61	-31.16	-13.01	-9.16	-7.94
D&A For EBITDA	1.1	1.07	0.98	0.78	0.09	0.07
EBIT	-35.46	-35.68	-32.14	-13.79	-9.24	-8.01

Source: S&P Capital IQ. Standard template.